Rishabh Drugs Private Limited
About Rishabh Drugs Private Limited
Data last updated:
Rishabh Drugs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 August 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33125DL1991PTC045326.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹7.09 Lakh. It is led by directors including Shivani Jain and Raj Pal Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B – 110 3rd Floor Malvia Nagar, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2022, the company reported a revenue of ₹5.95 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹12.1 Lakh (net margin 203.4%) and EBITDA of -₹4.9 Lakh (EBITDA margin -82.3%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rishabh Drugs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 110 3rd Floor Malvia Nagar, New Delhi, Delhi, India – 110017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rishabh Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rishabh Drugs Private Limited
FY 2024 filings availableRishabh Drugs Private Limited reported revenue of ₹5.95 Lakh (up 255% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 255% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹5.95 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -82.3% | ||||
| Net Profit Margin | 203.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rishabh Drugs Private Limited, buy the company report.
Board of directors of Rishabh Drugs Private Limited
Rishabh Drugs has 7 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivani Jain | Director | 28 Jan 2019 | 7 Years 9 Months | Current |
| Raj Pal Sharma | Director | 03 Oct 1991 | 35 Years 1 Months | Current |
| Pradeep Kumar Jain Also directs: Rajshi Drugs Private Limited | Director | 03 Oct 1991 | 35 Years 1 Months | Current |
| Apra Jain Also directs: Rajshi Farma Private Limited | Director | 03 Oct 1991 | 35 Years 1 Months | Current |
| Rahul Jain Also directs: Rajshi Drugs Private Limited | Director | 02 Aug 2016 | 10 Years 3 Months | Current |
| Surender Kumar Jain | Director | 03 Oct 1991 | 35 Years 1 Months | Current |
Auditor
Rishabh Drugs Private Limited is audited by A.R.GARG & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.R.GARG & CO. | FY 2022 | 001628C |
Shareholding
The shareholding of Rishabh Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rishabh Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rishabh Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rishabh Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rishabh Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rishabh Drugs Private Limited has 12 board changes on record since 1991: 7 appointments and 5 cessations. The latest: Naresh Chand Jain ceased to be Director on 19 Apr 2019.
3 earlier events are in the company report.
Frequently asked questions
Rishabh Drugs is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 August 1991 (35+ years old) and is registered under CIN U33125DL1991PTC045326.
Rishabh Drugs has 7 current directors:
- Shivani Jain - Director
- Raj Pal Sharma - Director
- Pradeep Kumar Jain - Director
- Apra Jain - Director
- Rahul Jain - Director
- Surender Kumar Jain - Director
- Vartika Jain - Director
The latest financial statements of Rishabh Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Rishabh Drugs is U33125DL1991PTC045326. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rishabh Drugs was incorporated on 09 August 1991, making it 35+ years old. It is registered with the Registrar of Companies, Delhi.
Naresh Chand Jain ceased to be Director on 19 Apr 2019. Shivani Jain was appointed as Director on 28 Jan 2019. Dinesh Kumar Nagpal ceased to be Director on 15 Jun 2018. Rishabh Drugs has 12 board changes on record in total.
The registered office of Rishabh Drugs is at B – 110 3rd Floor Malvia Nagar, New Delhi, Delhi, India – 110017.
Rishabh Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Rishabh Drugs is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.
Rishabh Drugs can be reached at its registered office: B – 110 3rd Floor Malvia Nagar, New Delhi, Delhi, India – 110017.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
